Endotoxins are a component of the outer membrane of Gram-negative bacteria. Their detection is vital in the pharmaceutical and medical industry for product quality and safety.
Dr Tobias Pusterla
Endotoxins are the main component of the outer membrane of the cell wall of Gram-negative bacteria. Typically, the term endotoxin is used synonymously with lipopolysaccharide (LPS), despite the fact that a few endotoxins are not LPS. The main function of endotoxins in bacteria is structural and protective.
Gram-negative bacteria are characterised by two membranes: the inner membrane surrounds the cytoplasma whereas the outer membrane separates the bacterial cell wall from the external environment. Thus, the outer membrane serves as the first line of defence against environmental threats. In most cases, the outer membrane is not a common phospholipid bilayer but an asymmetric bilayer comprising LPS in the outer layer and phospholipids in the inner one (fig.1).
Lipid A is the toxic component of endotoxins. It is a phosphorylated N-acetylglucosamine disaccharide containing a hydrophobic part (aliphatic chains of fatty acids) that anchors the endotoxin into the bacterial membrane. The rest of the endotoxin projects from the cell surface (fig.1). Although its structure is extremely conserved, it can undergo modifications in response to varying environmental conditions.1
The O-antigen is attached to the core polysaccharide and is the outermost part of the molecule. Although not toxic, it is the main immunogenic portion of endotoxins and consequently, it is a recognition target for antibodies and a major antigenic determinant. It is a repetitive glycan polymer made up of 3 to 5 sugars. It is the most diverse component of LPS: composition and length vary among species and even strains of bacteria.
Function of endotoxins
Endotoxins are the main component of the outer membrane of Gram-negative bacteria and of vital importance to their survival. Endotoxins contribute to the structural integrity of bacteria and act as a protective amphipathic barrier, shielding bacteria from chemical attacks. Endotoxins establish a barrier that is permeable only to hydrophilic molecules with low molecular weight, making Gram-negative bacteria resistant to many antimicrobial compounds.3
The reduced permeability to large hydrophilic molecules mainly results from the hydrophobic nature of Lipid A. The hydrophilic nature of the core oligosaccharide and O-antigen additionally make endotoxins impermeable to hydrophobic compounds.
In hosts, LPS protects bacteria from killing by phagocytes or serum components. Of notice, variations in the endotoxin structure establish different antigenic strains, increasing their chance of circumventing immunological responses that were previously developed against a specific strain of bacteria, allowing resistance to evolve.
As endotoxins are exposed on the surface of bacteria, the innate immune system has evolved to recognise them as a threat and to react accordingly to their presence. Endotoxins are pyrogens, provoking a strong innate immune response. When Gram-negative bacteria are killed by the immune system, fragments of their membrane containing endotoxins are released in the blood stream and may cause fever and diarrhoea. The presence of endotoxins in the blood (endotoxemia) typically leads to hypotension, respiratory failure and reduced oxygen delivery.4 Strong endotoxemia can lead to sepsis and eventually death.
Being the most conserved portion of LPS, the immune system has evolved to respond predominantly to Lipid A. The immune reaction is entirely innate and mediated by Toll-Like Receptor 4 (TLR4) in complex with MD2 (fig.4).5
TLR4 stimulates the secretion of pro-inflammatory cytokines and nitric oxide from macrophages and endothelial cells. In addition, endotoxins stimulate B-cell differentiation, proliferation and immunoglobulin secretion (mainly IgG and IgM). In macrophages and monocytes, endotoxins trigger the production of inflammatory cytokines (such as interleukin-1, 6 and 8, TNF and platelet-activating factor) and the consequent release of prostaglandins and leukotrienes.6 Moreover, the complement and coagulation cascades are activated inducing inflammation, vasodilation, chemotaxis of neutrophils, coagulation, bleeding and shock.
The O antigen is the immunogenic part of endotoxins, leading to antibody production from the host and contributing to evasion of phagocytosis. The involvement of the O antigen is confirmed by the fact that changes in its polysaccharide sequence significantly affect virulence. However, the mechanism underlying polysaccharide-driven virulence is not fully understood yet.
There are several methods to test for the presence of endotoxins. Invitroendotoxin testing methods include LAL assay andELISA. Both can be run onmicroplate readers, significantly increasing throughput and efficiency.
The Limulus Amebocyte Lysate (LAL) assay is a common endotoxin testing method. The LAL test is based on an extract of isolated amebocytes from the blood of the horseshoe crab. LAL tests are either chromogenic or turbidimetric. A LAL substitute test based on recombinant proteins and a fluorescent substrate is also available (fig. 5). Find more information on our blog post: “The LAL assay: a living fossil exploited to detect bacterial contamination.”
Endotoxins can also be assayed by ELISA which can detect either directly endotoxins or anti-endotoxin antibodies. However, the amphipathic nature of endotoxins negatively affects binding on ELISA plates and results in variable conformations of epitope binding sites. The result is generally low sensitivity and poor reproducibility.
Tzeng YL, Datta A, Kolli VK, Carlson RW, Stephens DS. Endotoxin of Neisseria meningitidis composed only of intact lipid A: inactivation of the meningococcal 3-deoxy-D-manno-octulosonic acid transferase. J Bacteriol. 2002 May;184(9):2379-88. doi: 10.1128/JB.184.9.2379-2388.2002. PMID: 11948150; PMCID: PMC134985.
Raetz, Christian R. H.; Guan, Ziqiang; Ingram, Brian O.; Six, David A.; Song, Feng; Wang, Xiaoyuan; Zhao, Jinshi. Discovery of new biosynthetic pathways: the lipid A story. Journal of Lipid Research (2009) S103-S108
Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiology and molecular biology reviews: MMBR. 2003;67(4):593–656. doi: 10.1128/mmbr.67.4.593-656.2003. PubMed PMID: ; PMCID: PMC309051.
Pelletier LL Jr. Microbiology of the Circulatory System. In: Baron S, editor. Medical Microbiology. 4th ed. Galveston (TX): University of Texas Medical Branch at Galveston; 1996. Chapter 94. PMID: 21413321.
Kilár A, Dörnyei Á, Kocsis B. Structural characterization of bacterial lipopolysaccharides with mass spectrometry and on- and off-line separation techniques. Mass Spectrom Rev. 2013 Mar-Apr;32(2):90-117. doi: 10.1002/mas.21352. Epub 2012 Nov 19. PMID: 23165926.
Beutler B, Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem. 1988;57:505-18. doi: 10.1146/annurev.bi.57.070188.002445. PMID: 3052281.